These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
Last week shows that oil prices are not the indicator for Middle East tensions they once were, and worries about global demand and growing U.S. production has changed that...Market Insiderread more
Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
The firing of the tear gas was the latest confrontation between police and protesters who have taken to the streets for over a month to fight a proposed extradition bill and...China Politicsread more
Amazon's new policy for account suspensions doesn't go far enough to protect sellers from potentially unfair and wrongful suspensions, merchants say.Technologyread more
There is no end in sight to the Boeing 737 Max grounding after two fatal crashes, prompting airlines to rethink their growth plans.Airlinesread more
After a year of flooding, Midwest farmers face a stifling heat wave that's spreading across the U.S.Weather & Natural Disastersread more
Gluskin Sheff's David Rosenberg is painting a painful picture for stocks as earnings season goes into full gear.Futures Nowread more
On Saturday, Disney's Marvel Studios announced its upcoming slate of superhero films during a panel at San Diego Comic-Con.Entertainmentread more
UBiome, a start-up that provides a test for people to monitor the health of the bacteria and other microorganisms that live in the body, has eliminated about than 10 percent of its staff in the US and additional positions overseas.
The company, which has raised more than $109 million in venture funding, recently laid off over 50 of its 300 employees. 30 were let go in the U.S., and a further 25 people from international offices, the company said.
The cuts were confirmed by Joel Jung, uBiome's chief financial officer, and CEO Jessica Richman. Jung told CNBC that the company is shifting to more of a focus on drugs and partnerships with pharmaceutical developers.
The company made the decision "to realign operations to set us up, and even add staff, as we expand our focus in therapeutics," Jung said.
To date, uBiome has developed a direct-to-consumer test to analyze the human microbiome, meaning it provides information to people about their gut health. The company began with an $89 test, called Explorer, which offers some insights into things like the amount of a specific type of bacteria in the gut and in other sites in exchange for a stool sample.
In recent years, it has unveiled new products that can be billed to insurers, including tests for sexually transmitted infections, flu pathogens and disease-carrying microbes in the gut.
Initial funding came through a $350,000 crowdfunding campaign on Indiegogo more than five years ago, which was particularly popular with the so-called "quantified self" community. The company has since raised money from 8VC, a firm started by Palantir co-founder Joe Lonsdale, as well as Y Combinator.